Gores, Gregory J.

Biliary repair and carcinogenesis are mediated by IL-33–dependent cholangiocyte proliferation

Li, J., Razumilava, N., Gores, G. J., Walters, S., Mizuochi, T., Mourya, R., Bessho, K., Wang, Y.-H., Glaser, S. S., Shivakumar, P., et al. (2014) · Journal of Clinical Investigation

IL-33, ST2, and ILC PathwaysPediatric Hepatobiliary Diseases and Treatments

Cited by 202

In primary sclerosing cholangitis, gallbladder polyps are frequently malignant

Buckles, D. C., Lindor, K. D., LaRusso, N. F., Petrovic, L. M., & Gores, G. J. (2002) · The American Journal of Gastroenterology

Cholangiocarcinoma and Gallbladder Cancer StudiesLiver Diseases and Immunity

Cited by 194

Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice

Guicciardi, M. E., Trussoni, C. E., Krishnan, A., Bronk, S. F., Lorenzo Pisarello, M. J., O'Hara, S. P., Splinter, P. L., Gao, Y., Vig, P., Revzin, A., et al. (2018) · Journal of Hepatology

Liver Diseases and ImmunityLiver physiology and pathology

Cited by 183

Bax inhibition protects against free fatty acid-induced lysosomal permeabilization

Feldstein, A. E., Werneburg, N. W., Li, Z., Bronk, S. F., & Gores, G. J. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology

Cell death mechanisms and regulationAutophagy in Disease and Therapy

Cited by 174

Prospective evaluation of esophageal varices in primary biliary cirrhosis: development, natural history, and influence on survival

Gores, G. J., Wiesner, R. H., Dickson, E. R., Zinsmeister, A. R., Jorgensen, R. A., & Langworthy, A. (1989) · Gastroenterology

Liver Disease and TransplantationLiver Diseases and Immunity

Cited by 173

CD40-mediated immune cell activation enhances response to anti-PD-1 in murine intrahepatic cholangiocarcinoma

Diggs, L. P., Ruf, B., Ma, C., Heinrich, B., Cui, L., Zhang, Q., McVey, J. C., Wabitsch, S., Heinrich, S., Rosato, U., et al. (2021) · Journal of Hepatology

Cholangiocarcinoma and Gallbladder Cancer StudiesCancer Immunotherapy and Biomarkers

Cited by 151

Targeting senescent cholangiocytes and activated fibroblasts with B‐cell lymphoma‐extra large inhibitors ameliorates fibrosis in multidrug resistance 2 gene knockout (Mdr2−/− ) mice

Moncsek, A., Al‐Suraih, M. S., Trussoni, C. E., O'Hara, S. P., Splinter, P. L., Zuber, C., Patsenker, E., Valli, P. V., Fingas, C. D., Weber, A., et al. (2018) · Hepatology

Liver Diseases and ImmunityLiver physiology and pathology

Cited by 136

YAP Tyrosine Phosphorylation and Nuclear Localization in Cholangiocarcinoma Cells Are Regulated by LCK and Independent of LATS Activity

Sugihara, T., Werneburg, N. W., Hernandez, M. C., Yang, L., Kabashima, A., Hirsova, P., Yohanathan, L., Sosa, C., Truty, M. J., Vasmatzis, G., et al. (2018) · Molecular Cancer Research

Hippo pathway signaling and YAP/TAZCholangiocarcinoma and Gallbladder Cancer Studies

Cited by 110

American Association for the Study of Liver Diseases endpoints conference: design and endpoints for clinical trials in primary biliary cirrhosis

Silveira, M. G., Brunt, E. M., Heathcote, J., Gores, G. J., Lindor, K. D., & Mayo, M. J. (2010) · Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 87

Early cholangiocarcinoma detection with magnetic resonance imaging versus ultrasound in primary sclerosing cholangitis

Eaton, J. E., Welle, C. L., Bakhshi, Z., Sheedy, S. P., Idilman, I. S., Gores, G. J., Rosen, C. B., Heimbach, J. K., Taner, T., Harnois, D. M., et al. (2021) · Hepatology

Cholangiocarcinoma and Gallbladder Cancer StudiesLiver Diseases and Immunity

Cited by 56

Changes in liver stiffness, measured by magnetic resonance elastography, associated with hepatic decompensation in patients with primary sclerosing cholangitis

Eaton, J. E., Sen, A., Hoodeshenas, S., Schleck, C. D., Harmsen, W. S., Gores, G. J., LaRusso, N. F., Gossard, A. A., Lazaridis, K. N., & Venkatesh, S. K. (2020) · Clinical Gastroenterology and Hepatology

Liver Diseases and ImmunityLiver Disease Diagnosis and Treatment

Cited by 56

Fibroblasts in liver cancer: functions and therapeutic translation

Affo, S., Filliol, A., Gores, G. J., & Schwabe, R. F. (2023) · The Lancet Gastroenterology & Hepatology

Liver physiology and pathologyHepatocellular Carcinoma Treatment and Prognosis

Cited by 49

Selected patients with unresectable perihilar cholangiocarcinoma (pCCA) derive long-term benefit from liver transplantation

Azad, A. I., Rosen, C. B., Taner, T., Heimbach, J. K., & Gores, G. J. (2020) · Cancers

Cholangiocarcinoma and Gallbladder Cancer StudiesPediatric Hepatobiliary Diseases and Treatments

Cited by 41

Epigenetics in the primary biliary cholangitis and primary sclerosing cholangitis

Cheung, A., LaRusso, N., Gores, G., & Lazaridis, K. (2017) · Seminars in Liver Disease

Liver Diseases and ImmunityEpigenetics and DNA Methylation

Cited by 37

The Emerging Role of Macrophages in Chronic Cholangiopathies Featuring Biliary Fibrosis: An Attractive Therapeutic Target for Orphan Diseases

Cadamuro, M., Girardi, N., Gores, G. J., Strazzabosco, M., & Fabris, L. (2020) · Frontiers in Medicine

Liver Diseases and ImmunityLiver physiology and pathology

Cited by 19

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) deletion in myeloid cells augments cholestatic liver injury

Krishnan, A., Ozturk, N. B., Cutshaw, K. A., Guicciardi, M. E., Kitagataya, T., Olson, K. E., Pavelko, K. D., Sherman, W., Wixom, A. Q., Jalan-Sakrikar, N., et al. (2024) · Scientific Reports

Liver physiology and pathologyLiver Diseases and Immunity

Cited by 8

Deep learning-based uncertainty quantification for quality assurance in hepatobiliary imaging-based techniques

Singh, Y., Andersen, J. B., Hathaway, Q., Venkatesh, S. K., Gores, G. J., & Erickson, B. (2025) · Oncotarget

AI in cancer detectionRadiomics and Machine Learning in Medical Imaging

Cited by 8